Untitled

March 8, 2026

New GLP-1 Side Effect Emerges, Surpassing 'Ozempic Face'

A new and distressing side effect of GLP-1 drugs like Ozempic is a severe, full-body itching that significantly impacts patient well-being, as reported in online forums. Clinical data shows 3-8% of users experience skin issues, which can range from mild injection site reactions to systemic sympto...

How AI Digital Twins Are Transforming Diabetes and Obesity Care

Innovative digital health solutions use a personalized, data-driven approach to manage chronic conditions by creating a virtual model of an individual's metabolism, offering actionable insights without relying solely on pharmaceuticals. A core feature is a predictive AI model that builds a "digit...

FDA Approves Wegovy Pill: New Weight Loss Tablet

The FDA has approved a daily oral pill version of the weight-loss drug Wegovy, offering a new, convenient alternative to the established weekly injection for managing obesity. Clinical trials showed the daily pill is highly effective, with participants achieving an average weight loss of 13.6% ov...